ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tysabri 150 mg/ml, Injektionslösung in einer Fertigspritze - 2
68008001 Biogen Switzerland AG
Tysabri 150 mg/ml, Injektionslösung in einer Fertigspritze04.11.2021
  04.11.2021
(L04AG03) 
WHO-DDD03.11.2026
01.99.2
01.99. 
B  
Yes 
IP 
1548.10Yes
    
10 %1700.05
  
7680680080016Biotechnologika
  
Composition
natalizumabum 150 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.45 mg.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Natalizumab150 mg/ml
BAG: Active AgentDose
Natalizumab150 mg
 
Inactive agents
Disodium Phosphate Heptahydrate
Sodium Chloride
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 80
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home